Variables asociadas a la exacerbación de la epoc

dc.contributor.authorPlata, Carolina
dc.contributor.authorL.Bautista, José
dc.contributor.authorRodríguez Bastos, Angela M.
dc.contributor.authorBecerra Toca, Daniela J.
dc.contributor.authorPeña Angarita, Omar O.
dc.contributor.authorRuiz Avella, Laura D.
dc.contributor.authorTorres Mendoza, Angela S.
dc.contributor.authorTorres Dueña, Diego
dc.contributor.authorCaputi Uribe, Juan Carlos Alberto
dc.contributor.cvlacTorres Dueñas, Diego [0000066885]spa
dc.contributor.googlescholarTorres Dueñas, Diego [XALS2s4AAAAJ]spa
dc.contributor.orcidTorres Dueñas, Diego [0000-0002-8006-7461]spa
dc.contributor.researchgroupSemilleros de Investigación UNABspa
dc.coverage.campusUNAB Campus Bucaramangaspa
dc.coverage.spatialBucaramanga (Santander, Colombia)spa
dc.coverage.temporal2018spa
dc.date.accessioned2023-08-22T23:35:13Z
dc.date.available2023-08-22T23:35:13Z
dc.date.issued2018-11
dc.description.abstractLa enfermedad pulmonar obstructiva crónica (EPOC),es una de las patologías respiratorias con alta prevalencia a nivel mundial y de gran trascendencia, teniendo en cuenta los datos de mortalidad asociados a los episodios de exacerbación, los cuales se han relacionado con diferentes factores clínicos y sociodemográficos.spa
dc.description.abstractenglishObstructive pulmonary disease chronic (COPD), is one of therespiratory pathologies with high prevalence world wide and of great importance,taking into account the data of mortality associated with episodes of exacerbation, which have been linked to various clinical factors and socio-demographic.spa
dc.description.learningmodalityModalidad Presencialspa
dc.description.sponsorshipUniversidad de Santanderspa
dc.format.mimetypeapplication/pdfspa
dc.identifier.instnameinstname:Universidad Autónoma de Bucaramanga - UNABspa
dc.identifier.issnISSN 2344-7079spa
dc.identifier.reponamereponame:Repositorio Institucional UNABspa
dc.identifier.repourlrepourl:https://repository.unab.edu.cospa
dc.identifier.urihttp://hdl.handle.net/20.500.12749/21348
dc.language.isospaspa
dc.publisher.deparmentSistema de Investigación SIUNABspa
dc.publisher.facultyFacultad Ciencias de la Salud
dc.publisher.grantorUniversidad Autónoma de Bucaramanga UNABspa
dc.publisher.programPregrado Medicina
dc.relation.ispartofseriesGeneración Creativa : Encuentro de Semilleros de Investigación UNABspa
dc.relation.referencesWorld Health Organization. World Health Statistics. WHO (Geneva) 2008; (Accedido en Agosto, 2018). DOI: http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf? ua=1spa
dc.relation.referencesSoler Cataluña JJ, Martínez García MA, Román Sánchez P, et al. 2005. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax. 60(11), (Nov. 2005), 925-31.spa
dc.relation.references1. GBD 2015 Chronic Respiratory Disease Collaborators. 2017. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 5, (Sept. 2017), 691–706. DOI= https://doi.org/10.1016/S2213- 2600(17)30293-Xspa
dc.relation.referencesVestbo J, Hurd S, Agustí A, Jones P, Vogelmeier C, Anzueto A, et al. 2013. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 187 (4), (Feb. 2013), 347–365.DOI = https://doi.org/10.1164/rccm.201204-0596PPspa
dc.relation.referencesBuist AS, McBurnie MA, Vollmer WM, et al. 2007. International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet. 370(9589), (Sept. 2007), 741-50.spa
dc.relation.referencesHan MK, Dransfield MT, Martinez FJ. 2018. Chronic obstructive pulmonary disease: Definition, clinical manifestations , diagnosis, and staging. (Jul. 2018).spa
dc.relation.referencesVestbo J, Hurd S, Agustí A, Jones P, Vogelmeier C, Anzueto A, et al. 2013. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 187(4), (Feb. 2013), 347–365.spa
dc.relation.referencesDonaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. 2002. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 57, (Oct. 2002), 847–52.spa
dc.relation.referencesSoler Cataluña JJ, Martínez García MA. 2007. Factores pronósticos en la EPOC. Arch Bronconeumol. 43(12), (Dic. 2007), 680-91.spa
dc.relation.referencesGlobal Initiative for Chronic Obstructive Lung Disease (GOLD). 2018. Global Strategy for the Diagnosis, Management and Prevention of chronic obstructive pulmonary disease: 2018 Report. http://www.goldcopd.org (Accessed on July, 2018). DOI= https://goldcopd.org/wpcontent/uploads/2017/11/GOLD-2018-v6.0-FINALrevised-20-Nov_WMS.pdfspa
dc.relation.referencesMiravitlles M, Guerrero T, Mayordomo C, et al. 2000. Factors associated with increased risk of exacerbation and hospital admission in a cohort of ambulatory COPD patients: a multiple logistic regression analysis. The EOLO Study Group. Respiration. 67(5), (Sept-Oct. 2000), 495-501.spa
dc.relation.urihttp://hdl.handle.net/20.500.12749/14242
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.creativecommonsAtribución-NoComercial-SinDerivadas 2.5 Colombia*
dc.rights.localAbierto (Texto Completo)spa
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/2.5/co/*
dc.sourcePlata, C., et al. (2018). Variables asociadas a la exacerbación de la epoc. Recuperado de: http://hdl.handle.net/20.500.12749/21348spa
dc.subject.keywordsMedicinespa
dc.subject.keywordsChronic obstructive pulmonary diseasespa
dc.subject.keywordsClinical researchspa
dc.subject.keywordsExacerbationsspa
dc.subject.keywordsVariablesspa
dc.subject.keywordsRiskspa
dc.subject.keywordsSociodemographic factorsspa
dc.subject.keywordsDeath causespa
dc.subject.lembMedicinaspa
dc.subject.lembEnfermedad pulmonar obstructiva crónicaspa
dc.subject.lembExacerbacionesspa
dc.subject.lembInvestigación clínicaspa
dc.subject.proposalVariablesspa
dc.subject.proposalRiesgospa
dc.subject.proposalFactores sociodemográficosspa
dc.subject.proposalCausa de muertespa
dc.subject.proposalClinical researchspa
dc.titleVariables asociadas a la exacerbación de la epocspa
dc.title.translatedVariables Associated with COPD Exacerbationspa
dc.typeConferenceeng
dc.type.coarhttp://purl.org/coar/resource_type/c_f744
dc.type.coarversionhttp://purl.org/coar/version/c_ab4af688f83e57aaspa
dc.type.driverinfo:eu-repo/semantics/conferenceProceedingsspa
dc.type.hasversioninfo:eu-repo/semantics/acceptedVersionspa
dc.type.localMemoria de eventosspa
dc.type.redcolhttp://purl.org/redcol/resource_type/EC_AC

Archivos

Bloque original

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
2018_Articulo_Torres_Dueñas_Diego.pdf
Tamaño:
158.54 KB
Formato:
Adobe Portable Document Format
Descripción:
Artículo

Bloque de licencias

Mostrando 1 - 1 de 1
Cargando...
Miniatura
Nombre:
license.txt
Tamaño:
829 B
Formato:
Item-specific license agreed upon to submission
Descripción: